Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 174 results found. Search for [ Bayer ]

Results 140 to 160 of 174
BT Online Bureau
August 22, 2012
The Supreme Court will hear final arguments from in a key patent dispute between Swiss drugmaker Novartis and India's patent office September 11.
May 24, 2012
There seems to be no end to the Air India mess, with pilots demanding exclusive training rights on Dreamliner jet planes.
June 7, 2012
Starring: J.S. Sarma, Rahul Khullar, Dev Amritesh, Y.K. Hamied, Hiroyuki Suzuki, Pallavi Jha

Mail Today Bureau
Mumbai, May 17, 2012
The Mumbai-based company, flushed with cash after it sold formulations business to US-based Abbott Laboratories for $3.72 billion in 2010, will acquire healthcare data provider Decision Resources Group (DRG) for $635 million (Rs 3,400 crore).

Berlin, May 10, 2012
Bayer holds the patent for Nexavar till 2020 and it will \"vigorously defend its patent within the available legal framework\".

New Delhi, May 7, 2012
In March this year, India had invoked a law permitting Hyderabad-based Natco Pharma to manufacture and sell cancer-treatment drug Nexavar at a price over 30 times lower than charged by its patent-holder Bayer Corporation.

E Kumar Sharma
Hyderabad, May 4, 2012
Cipla says that its decision to slash prices of cancer drugs is purely a humanitarian gesture. In cancer treatment, it is planning to do what it did in anti-AIDS drugs many years ago by launching them at low prices.

New Delhi, May 3, 2012
Cipla Chairman and MD YK Hamied said, \"This initiative of price reduction is a humanitarian approach by Cipla to support cancer patients.\"

Associated Press
New York, April 18, 2012
Nestle is one of the world's largest sellers of infant formula and may face some antitrust hurdles to complete the deal, according to a report in The Wall Street Journal.

Suman Layak and Geetanjali Shukla
April 12, 2012
Harsh Goenka, chairman, RPG Enterprises, in a free-wheeling, nearly two-hour-long, chat with Business Today's Suman Layak and Geetanjali Shukla discusses his companies' overseas plans.

Dinesh C. Sharma
New Delhi, March 28, 2012
The landmark decision of the patent office to break the monopoly of Bayer in kidney and liver cancer drugs recently is already having a rippling effect.

E. Kumar Sharma
March 27, 2012
Compulsory licences have brought domestic and multinational pharma companies face to face. Although domestic firms are getting to make cheaper versions of patented drugs, will this be enough to cure the country of its health care ills?

E Kumar Sharma
March 13, 2012
This is the first time an Indian company has been granted a compulsory licence, which means the patent holders grant licences to generic drug makers.

N. Madhavan
November 28, 2011
The formerly slow moving agrochemicals sector is suddenly booming. Apart from farm labour shortage, several other developments are fuelling the increasing use of agrochemicals. Crucially, farmers are becoming more aware of their benefits.

Mumbai, April 11, 2011
Amid news that the company is likely to enter into a marketing tie up with US drug major Merck & Co, Sun Pharma's shares jumped to touch Rs 455.90 on BSE.

Mumbai, April 1, 2011
The company, which is engaged in the agrochemicals business, rose by 8.98 per cent to an early peak of Rs 999 on the BSE.

R Shree Ram
January 5, 2011
Experts list out the companies that are likely to do well this year and the reasons you would do well to pick them up.Will commodities beat stocks this year?Post Comment

Tanvi Varma
November 10, 2010
Small- and mid-cap funds have been outperformers in the past one year, but this should not make them the mainstay of your fund portfolio.

Tanvi Varma/Money Today
December 20, 2010
Small- and mid-cap funds have been outperformers in the past one year, but this should not make them the mainstay of your fund portfolio.
October 9, 2010
Here is a look at people, places and products doing the rounds these days.

PAGES 8 OF 9  6789